Literature DB >> 22751007

RNA silencing as a cellular defense against HIV-1 infection: progress and issues.

Viraj R Sanghvi1, Laura F Steel.   

Abstract

MicroRNAs (miRNAs) are known to have a role in gene regulation that is closely integrated into the pathways that control virtually all fundamental cell processes of growth, differentiation, metabolism, and death. Whether silencing RNAs and the cellular pathways that generate them are also used in antiviral defense in higher eukaryotes, as they are in plants and lower eukaryotes, has been the subject of much study. Results to date point to a complex interplay between viruses and vertebrate host cells that can vary considerably among different viruses. Here, we review current knowledge regarding interactions between HIV-1 and host cell RNA silencing mechanisms. Important questions in this field remain unresolved, including whether HIV-1 itself encodes small silencing RNAs that might either promote or repress its replication, whether host cell miRNAs can directly target viral transcripts or can alter the course of infection indirectly through effects on cellular genes necessary for viral replication, and whether HIV-1 produces proteins or RNAs that suppress the host-silencing pathway. We summarize evidence and controversies related to the potential role of RNA silencing pathways as a defense against HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22751007     DOI: 10.1096/fj.12-210765

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  8 in total

1.  A Computational Approach for Predicting Role of Human MicroRNAs in MERS-CoV Genome.

Authors:  Md Mahmudul Hasan; Rozina Akter; Md Shahin Ullah; Md Jaynul Abedin; G M Ahsan Ullah; Md Zakir Hossain
Journal:  Adv Bioinformatics       Date:  2014-12-23

2.  Expression of Human Immunodeficiency Virus type 1 (HIV-1) coat protein genes in plants using cotton leaf curl Multan betasatellite-based vector.

Authors:  Elham Ataie Kachoie; Seyed Ali Akbar Behjatnia; Sara Kharazmi
Journal:  PLoS One       Date:  2018-01-05       Impact factor: 3.240

Review 3.  The Potential Therapeutic Effect of RNA Interference and Natural Products on COVID-19: A Review of the Coronaviruses Infection.

Authors:  Mohammad Reza Kalhori; Fatemeh Saadatpour; Ehsan Arefian; Masoud Soleimani; Mohammad Hosien Farzaei; Ina Yosifova Aneva; Javier Echeverría
Journal:  Front Pharmacol       Date:  2021-02-23       Impact factor: 5.810

4.  Identification of homologous human miRNAs as antivirals towards COVID-19 genome.

Authors:  Jitender Singh; Ashvinder Raina; Namrata Sangwan; Arushi Chauhan; Krishan L Khanduja; Pramod K Avti
Journal:  Adv Cell Gene Ther       Date:  2021-10-10

5.  A Panel of Eight miRNAs Is Deregulated in HTLV-2 Infected PBMCs and BJABGu Cell Line.

Authors:  Elisabetta Pilotti; Attilio Cannata; Giacomo Magnani; Fabio Bignami; Andrea Corsi; Maria Teresa Valenti; Mariam Shallak; Greta Forlani; Maria Grazia Romanelli
Journal:  Int J Mol Sci       Date:  2022-07-08       Impact factor: 6.208

Review 6.  Biogenesis and Biological Activity of Secondary siRNAs in Plants.

Authors:  Franck Vazquez; Thomas Hohn
Journal:  Scientifica (Cairo)       Date:  2013-02-12

7.  The Effect of MicroRNA bantam on Baculovirus AcMNPV Infection in Vitro and in Vivo.

Authors:  Xiaojie Shi; Zihan Ran; Sisi Li; Juan Yin; Jiang Zhong
Journal:  Viruses       Date:  2016-05-16       Impact factor: 5.048

8.  The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities.

Authors:  Elif Damla Arisan; Alwyn Dart; Guy H Grant; Serdar Arisan; Songul Cuhadaroglu; Sigrun Lange; Pinar Uysal-Onganer
Journal:  Viruses       Date:  2020-06-04       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.